NCT06740448

Brief Summary

A diet high in flavonoids is becoming more established as beneficial to human health. Recent data suggest that the regular consumption of flavanols can reduce the numbers of deaths by cardiovascular disease at a population level. The mechanisms for these reductions in deaths by cardiovascular disease are still debated and little is known about their impacts on factors affecting blood viscosity. The metabolism of flavanols is complex, with different metabolites being predominant in the blood at different time points. Therefore, in this study, we will investigate the effects of green tea, a well-known source of flavanols, on blood viscosity at different time points. This will be assessed in healthy individuals with no history of cardiovascular disease aged 65+ years old. Blood viscosity will be measured before, and 2hours and 8hours after the consumption of green tea.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 18, 2024

Completed
14 days until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

December 27, 2024

Status Verified

December 1, 2024

Enrollment Period

4 months

First QC Date

December 13, 2024

Last Update Submit

December 19, 2024

Conditions

Keywords

FlavanolGreen TeaBlood ViscosityOlder Adults

Outcome Measures

Primary Outcomes (1)

  • Whole Blood Viscosity

    Baseline to 2 hours and 8 hours

Secondary Outcomes (3)

  • Plasma Viscosity

    Baseline to 2 hours and 8 hours

  • Blood Triglycerides

    Baseline to 2 hours and 8 hours

  • C-reactive protein

    Baseline to 2 hours and 8 hours

Study Arms (2)

Green Tea

EXPERIMENTAL

200 mL green tea on first visit

Dietary Supplement: Green TeaDietary Supplement: Control (Hot Water)

Hot Water

PLACEBO COMPARATOR

200 mL hot water on first visit

Dietary Supplement: Green TeaDietary Supplement: Control (Hot Water)

Interventions

Green TeaDIETARY_SUPPLEMENT

200 mL Green Tea

Green TeaHot Water
Control (Hot Water)DIETARY_SUPPLEMENT

200 mL hot water

Green TeaHot Water

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Participants ages 65 years and older
  • Non-smoker Participants with at least 2 'good' veins for giving blood

You may not qualify if:

  • Participants under (BMI \<18.5 kg/m2) or extremely over-nourished (BMI \>30 kg/m2)
  • Participants on prescription medication for CVD or regularly taking blood thinning drugs such as aspirin.
  • Participants with a history of CVD or CVD in immediate family/ high resting blood pressure
  • Participants with any food allergies/intolerances
  • Participants with a history of metabolic diseases/ high resting blood glucose
  • Participants with high resting levels of inflammatory markers (CRP)
  • Participants on hormone replacement therapy
  • Participants with abnormal red blood cell count or low haemoglobin stores

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hugh Sinclaire Unit of Human Nutrition, Departmeant of Food and Nutrition, University of Reading

Reading, United Kingdom

Location

MeSH Terms

Conditions

Cardiovascular Diseases

Interventions

Tea

Intervention Hierarchy (Ancestors)

Plant PreparationsBiological ProductsComplex MixturesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Central Study Contacts

Emily Waterfield, MSci

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: A randomised, single blind, crossover design with a 3 week washout period between conditions investigating the acute effects (over 2 and 8 hours) of green tea on blood viscosity
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 13, 2024

First Posted

December 18, 2024

Study Start

January 1, 2025

Primary Completion

May 1, 2025

Study Completion

May 1, 2025

Last Updated

December 27, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

Locations